Psychopathology of addiction: Can the SCL90-based five-dimensional structure differentiate Heroin Use Disorder from a non-substance-related addictive disorder such as Gambling Disorder?
Tóm tắt
In the Gambling Disorder (GD), there is no exogenous drug administration that acts as the central core of the traditional meaning of addiction. A specific psychopathology of Substance Use Disorders has been proposed recently. In a sample of Heroin Use Disorder (HUD) patients entering opioid agonist treatment, it became possible to identify a group of 5 mutually exclusive psychiatric dimensions: Worthlessness-Being trapped (W-BT), Somatic Symptoms (SS), Sensitivity-Psychoticism (SP), Panic Anxiety (PA) and Violence-Suicide (VS). The specificity of these dimensions was suggested by the absence of their correlations with treatment choice, active substance use, psychiatric comorbidity and the principal substance of abuse and by the opportunity, through their use, of fully discriminating HUD from Major Depression patients and, partially, from obese non-psychiatric patients. To further support this specificity in the present study, we tested the feasibility of discriminating HUD patients from those affected by a non-substance-related addictive behaviour, such as GD. In this way, we also investigated the psychopathological peculiarities of GD patients. We compared the severity and frequency of each of the five aspects found by us, in 972 (83.5% males; mean age 30.12 ± 6.6) HUD and 110 (50% males; average age 30.12 ± 6.6) GD patients at univariate (T test; Chi square) and multivariate (discriminant analysis and logistic regression) level. HUD patients showed higher general psychopathology indexes than GD patients. The severity of all five psychopathological dimensions was significantly greater in HUD patients. Discriminant analysis revealed that SS and VS severity were able to discriminate between HUD (higher severity) and GD patients (lower severity), whereas PA and SP could not. W-BT severity was negatively correlated with SS and VS; GD patients were distinguished by low scores for SS and VS low scores associated with high ones for W-BT. Psychopathological subtypes characterized by SS and VS symptomatology were better represented in HUD patients, whereas PA symptomatology was more frequent in GD individuals. No differences were observed regarding the W-BT and SP dimensions. At multivariate level, the one prominent characteristic of HUD patients was the presence of SS (OR = 5.43) as a prominent qualification for psychopathological status. Apart from the lower severity of all psychopathological dimensions, only the lower frequency of SS typology seems to be the prominent factor in GD patients. The SCL90-defined structure of opioid addiction seems to be useful even in non-substance-related addictive disorders, as in the case of GD patients, further supporting the possible existence of a psychopathology specific to addiction.
Tài liệu tham khảo
Rash CJ, Petry NM. Gambling Disorder in the DSM-5: opportunities to improve diagnosis and treatment especially in substance use and homeless populations. Curr Addict Rep. 2016;3(3):249–53.
Yau YH, Potenza MN. Gambling Disorder and other behavioral addictions: recognition and treatment. Harv Rev Psychiatry. 2015;23(2):134–46.
Weinstock J, Rash CJ. Clinical and research implications of Gambling Disorder in DSM-5. Curr Addict Rep. 2014;1(3):159–65.
Schuckit MA. Editor’s corner: DSM-5–ready or not, here it comes. J Stud Alcohol Drugs. 2013;74(5):661–3.
Kyngdon A, Dickerson M. An experimental study of the effect of prior alcohol consumption on a simulated gambling activity. Addiction. 1999;94(5):697–707.
Nower L, Blaszczynski A. Recovery in pathological gambling: an imprecise concept. Subst Use Misuse. 2008;43(12–13):1844–64.
de Castro V, Fong T, Rosenthal RJ, Tavares H. A comparison of craving and emotional states between pathological gamblers and alcoholics. Addict Behav. 2007;32(8):1555–64.
Griffiths M. Tolerance in gambling: an objective measure using the psychophysiological analysis of male fruit machine gamblers. Addict Behav. 1993;18(3):365–72.
Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res. 2000;126:325–41.
Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993;18(3):247–91.
Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Invest. 2003;111(10):1444–51.
Goldstein RZ, Volkow ND. Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. Nat Rev Neurosci. 2011;12(11):652–69.
Hommer DW, Bjork JM, Gilman JM. Imaging brain response to reward in addictive disorders. Ann N Y Acad Sci. 2011;1216:50–61.
Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci. 2005;8(2):147–8.
Grant JE, Potenza MN. Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry. 2004;16(1):27–34.
Lawrence AJ, Luty J, Bogdan NA, Sahakian BJ, Clark L. Impulsivity and response inhibition in alcohol dependence and problem gambling. Psychopharmacology. 2009;207(1):163–72.
Leeman RF, Potenza MN. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology. 2012;219(2):469–90.
Blaszczynski A, Steel Z, McConaghy N. Impulsivity in pathological gambling: the antisocial impulsivist. Addiction. 1997;92(1):75–87.
Petry NM. Substance abuse, pathological gambling, and impulsiveness. Drug Alcohol Depend. 2001;63(1):29–38.
Potenza MN, Steinberg MA, Skudlarski P, Fulbright RK, Lacadie CM, Wilber MK, Rounsaville BJ, Gore JC, Wexler BE. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2003;60(8):828–36.
Cavedini P, Riboldi G, Keller R, D’Annucci A, Bellodi L. Frontal lobe dysfunction in pathological gambling patients. Biol Psychiatry. 2002;51(4):334–41.
Zhou Y, Proudnikov D, Yuferov V, Kreek MJ. Drug-induced and genetic alterations in stress-responsive systems: implications for specific addictive diseases. Brain Res. 2010;1314:235–52.
el-Guebaly N, Mudry T, Zohar J, Tavares H, Potenza MN. Compulsive features in behavioural addictions: the case of pathological gambling. Addiction. 2012;107(10):1726–34.
Black DW, Moyer T, Schlosser S. Quality of life and family history in pathological gambling. J Nerv Ment Dis. 2003;191(2):124–6.
Lobo DS, Kennedy JL. Genetic aspects of pathological gambling: a complex disorder with shared genetic vulnerabilities. Addiction. 2009;104(9):1454–65.
Rennert L, Denis C, Peer K, Lynch KG, Gelernter J, Kranzler HR. DSM-5 gambling disorder: prevalence and characteristics in a substance use disorder sample. Exp Clin Psychopharmacol. 2014;22(1):50–6.
Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101(Suppl 1):142–51.
Lorains FK, Cowlishaw S, Thomas SA. Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys. Addiction. 2011;106(3):490–8.
Cowlishaw S, Merkouris S, Chapman A, Radermacher H. Pathological and problem gambling in substance use treatment: a systematic review and meta-analysis. J Subst Abuse Treat. 2014;46(2):98–105.
Rash CJ, Weinstock J, Petry NM. Drinking patterns of pathological gamblers before, during, and after gambling treatment. Psychol Addict Behav. 2011;25(4):664–74.
Hodgins DC, el-Guebaly N. The influence of substance dependence and mood disorders on outcome from pathological gambling: 5-year follow-up. J Gambl Stud. 2010;26(1):117–27.
Kessler RC, Hwang I, LaBrie R, Petukhova M, Sampson NA, Winters KC, Shaffer HJ. DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol Med. 2008;38(9):1351–60.
Bergh C, Kuhlhorn E. Social, psychological and physical consequences of pathological gambling in Sweden. J Gambl Stud. 1994;10(3):275–85.
McCormick RA, Russo AM, Ramirez LF, Taber JI. Affective disorders among pathological gamblers seeking treatment. Am J Psychiatry. 1984;141(2):215–8.
Dowling NA, Cowlishaw S, Jackson AC, Merkouris SS, Francis KL, Christensen DR. Prevalence of psychiatric co-morbidity in treatment-seeking problem gamblers: a systematic review and meta-analysis. Aust N Z J Psychiatry. 2015;49(6):519–39.
Petry NM, Stinson FS, Grant BF. Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2005;66(5):564–74.
Maremmani I, Pani PP, Pacini M, Bizzarri JV, Trogu E, Maremmani AGI, Perugi G, Gerra G, Dell’Osso L. Subtyping Patients with Heroin Addiction at treatment entry: factors derived from the SCL-90. Ann Gen Psychiatry. 2010;9(1):15.
Pani PP, Maremmani AGI, Trogu E, Vigna-Taglianti F, Mathis F, Diecidue R, Kirchmayer U, Amato L, Ghibaudi J, Camposeragna A, et al. Psychopathology of addiction: May a SCL-90 based five dimensions structure be applied irrespectively of the involved drug? Ann Gen Psychiatry. 2016;15:13.
Pani PP, Maremmani AGI, Trogu E, Vigna-Taglianti F, Mathis F, Diecidue R, Kirchmayer U, Amato L, Davoli M, Ghibaudi J, et al. Psychic structure of opioid addiction: impact of lifetime psychiatric problems on SCL-90-based psychopathologic dimensions in heroin-dependent patients. Addict Disord Treat. 2016;15(1):6–16.
Pani PP, Maremmani AGI, Trogu E, Vigna-Taglianti F, Mathis F, Diecidue R, Kirchmayer U, Amato L, Davoli M, Ghibaudi J, et al. Psychopathological symptoms in detoxified and non-detoxified heroin-dependent patients entering residential treatment. Heroin Addict Relat Clin Probl. 2015;17(2–3):17–24.
Pani PP, Trogu E, Vigna-Taglianti F, Mathis F, Diecidue R, Kirchmayer U, Amato L, Davoli M, Ghibaudi J, Camposeragna A, et al. Psychopathological symptoms of patients with heroin addiction entering opioid agonist or therapeutic community treatment. Ann Gen Psychiatry. 2014;13(1):35.
Maremmani I, Pacini M, Lubrano S, Perugi G, Tagliamonte A, Pani PP, Gerra G, Shinderman M. Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis). Eur Addict Res. 2008;14(3):134–42.
Maremmani AGI, Pani PP, Trogu E, Vigna-Taglianti F, Mathis F, Diecidue R, Kirchmayer U, Amato L, Ghibaudi J, Composeragna A, et al. The impact of psychopathological subtypes on retention rate of patients with substance use disorders entering residential therapeutic community treatment. Ann Gen Psychiatry. 2016;15(1):29.
Maremmani AGI, Cerniglia L, Cimino S, Bacciardi S, Rovai L, Rugani F, Massimetti E, Gazzarrini D, Pallucchini A, Pani PP, et al. Towards a specific psychopathology of heroin addiction. Comparison between Heroin Use Disorder and Major Depression patients. Heroin Addict Relat Clin Probl. 2015;17(6):9–16.
Maremmani AGI, Cerniglia L, Cimino S, Bacciardi S, Rovai L, Pallucchini A, Spera V, Perugi G, Maremmani I. Further evidence of a specific psychopathology of addiction. Differentiation from other psychiatric psychopathological dimensions (such as obesity). Int J Environ Res Public Health. 2017;14(8):943.
Derogatis LR, Lipman RS, Rickels K. The Hopkins Symptom Checklist (HSCL)—A self report symptom inventory. Behav Sci. 1974;19:1–16.
Maremmani AGI, Rovai L, Maremmani I. Heroin addicts’ psychopathological subtypes. Correlations with the natural history of illness. Heroin Addict Relat Clin Probl. 2012;14(1):11–22.
First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV Axis I disorders (SCID-I), Clinician Version. Arlington: American Psychiatric Publishing, Inc; 1997.
Blaszczynski AP, McConaghy N. SCL-90 assessed psychopathology in pathological gamblers. Psychol Rep. 1988;62(2):547–52.
Jimenez-Murcia S, Del Pino-Gutierrez A, Fernandez-Aranda F, Granero R, Hakansson A, Tarrega S, Valdeperez A, Aymami N, Gomez-Pena M, Moragas L, et al. Treatment outcome in male Gambling Disorder patients associated with alcohol use. Front Psychol. 2016;7:465.
Gonzalez-Ibanez A, Aymami MN, Jimenez S, Domenech JM, Granero R, Lourido-Ferreira MR. Assessment of pathological gamblers who use slot machines. Psychol Rep. 2003;93(3 Pt 1):707–16.
Gonzalez-Ibanez A, Mora M, Gutierrez-Maldonado J, Ariza A, Lourido-Ferreira MR. Pathological gambling and age: differences in personality, psychopathology, and response to treatment variables. Addict Behav. 2005;30(2):383–8.
Jimenez-Murcia S, Alvarez-Moya EM, Stinchfield R, Fernandez-Aranda F, Granero R, Aymami N, Gomez-Pena M, Jaurrieta N, Bove F, Menchon JM. Age of onset in pathological gambling: clinical, therapeutic and personality correlates. J Gambl Stud. 2010;26(2):235–48.
Bonnaire C, Kovess-Masfety V, Guignard R, Richard JB, du Roscoat E, Beck F. Gambling type, substance abuse, health and psychosocial correlates of male and female problem gamblers in a nationally representative French Sample. J Gambl Stud 2017;33(2):343–69.
Castren S, Salonen AH, Alho H, Lahti T, Simojoki K. Past-year gambling behaviour among patients receiving opioid substitution treatment. Subst Abuse Treat Prev Policy. 2015;10:4.
Peles E, Schreiber S, Adelson M. Pathological gambling and obsessive compulsive disorder among methadone maintenance treatment patients. J Addict Dis. 2009;28(3):199–207.
Peles E, Schreiber S, Linzy S, Adelson M. Pathological gambling in methadone maintenance clinics where gambling is legal versus illegal. Am J Orthopsychiatry. 2010;80(3):311–6.
Spunt B. Pathological gambling and substance misuse. Subst Use Misuse. 2002;37(8–10):1299–304.
Toneatto T, Brennan J. Pathological gambling in treatment-seeking substance abusers. Addict Behav. 2002;27(3):465–9.
Weinstock J, Blanco C, Petry NM. Health correlates of pathological gambling in a methadone maintenance clinic. Exp Clin Psychopharmacol. 2006;14(1):87–93.